---
layout: default
title: Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble
---

# Adaptable Segmentation Pipeline for Diverse Brain Tumors with Radiomic-guided Subtyping and Lesion-Wise Model Ensemble

**arXiv**: [2512.14648v1](https://arxiv.org/abs/2512.14648) | [PDF](https://arxiv.org/pdf/2512.14648.pdf)

**ä½œè€…**: Daniel CapellÃ¡n-MartÃ­n, Abhijeet Parida, Zhifan Jiang, Nishad Kulkarni, Krithika Iyer, Austin Tapp, Syed Muhammad Anwar, MarÃ­a J. Ledesma-Carbayo, Marius George Linguraru

**åˆ†ç±»**: cs.CV, eess.IV

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

**å¤‡æ³¨**: 12 pages, 5 figures, 3 tables. Algorithm presented at MICCAI BraTS 2025

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºåŸºäºŽæ”¾å°„ç»„å­¦å¼•å¯¼å’Œç—…ç¶çº§æ¨¡åž‹é›†æˆçš„è„‘è‚¿ç˜¤è‡ªé€‚åº”åˆ†å‰²æµç¨‹**

ðŸŽ¯ **åŒ¹é…é¢†åŸŸ**: **å¼ºåŒ–å­¦ä¹ ä¸Žæ¨¡ä»¿å­¦ä¹  (RL & IL)**

**å…³é”®è¯**: `è„‘è‚¿ç˜¤åˆ†å‰²` `æ”¾å°„ç»„å­¦` `æ¨¡åž‹é›†æˆ` `æ·±åº¦å­¦ä¹ ` `åŒ»å­¦å›¾åƒåˆ†æž`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. çŽ°æœ‰è„‘è‚¿ç˜¤åˆ†å‰²æ–¹æ³•éš¾ä»¥åº”å¯¹è‚¿ç˜¤ç±»åž‹å¤šæ ·æ€§ï¼Œæ³›åŒ–èƒ½åŠ›ä¸è¶³ã€‚
2. è¯¥è®ºæ–‡æå‡ºä¸€ç§è‡ªé€‚åº”åˆ†å‰²æµç¨‹ï¼Œåˆ©ç”¨æ”¾å°„ç»„å­¦ç‰¹å¾å¼•å¯¼è‚¿ç˜¤äºšåž‹è¯†åˆ«ï¼Œå¹¶è¿›è¡Œç—…ç¶çº§æ¨¡åž‹é›†æˆã€‚
3. å®žéªŒç»“æžœè¡¨æ˜Žï¼Œè¯¥æµç¨‹åœ¨å¤šä¸ª BraTS æŒ‘æˆ˜èµ›æ•°æ®é›†ä¸Šå–å¾—äº†ä¸Žé¡¶å°–ç®—æ³•ç›¸å½“çš„æ€§èƒ½ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åœ¨å¤šå‚æ•°ç£å…±æŒ¯æˆåƒï¼ˆMRIï¼‰ä¸Šå¯¹ä¸åŒè„‘è‚¿ç˜¤è¿›è¡Œé²æ£’ä¸”æ³›åŒ–çš„åˆ†å‰²ä»ç„¶å¾ˆå›°éš¾ï¼Œå› ä¸ºè‚¿ç˜¤ç±»åž‹å·®å¼‚å¾ˆå¤§ã€‚BraTS 2025 Lighthouse Challenge åœ¨æˆäººå’Œå„¿ç«¥è‚¿ç˜¤çš„é«˜è´¨é‡å¤šæ ·åŒ–æ•°æ®é›†ä¸Šå¯¹åˆ†å‰²æ–¹æ³•è¿›è¡ŒåŸºå‡†æµ‹è¯•ï¼ŒåŒ…æ‹¬ï¼šå¤šè”ç›Ÿå›½é™…å„¿ç§‘è„‘è‚¿ç˜¤åˆ†å‰²ï¼ˆPEDï¼‰ã€æœ¯å‰è„‘è†œç˜¤è‚¿ç˜¤åˆ†å‰²ï¼ˆMENï¼‰ã€è„‘è†œç˜¤æ”¾å°„æ²»ç–—åˆ†å‰²ï¼ˆMEN-RTï¼‰ä»¥åŠæ²»ç–—å‰å’Œæ²»ç–—åŽè„‘è½¬ç§»ç˜¤åˆ†å‰²ï¼ˆMETï¼‰ã€‚æˆ‘ä»¬æå‡ºäº†ä¸€ç§çµæ´»ã€æ¨¡å—åŒ–å’Œè‡ªé€‚åº”çš„æµç¨‹ï¼Œé€šè¿‡é€‰æ‹©å’Œç»„åˆæœ€å…ˆè¿›çš„æ¨¡åž‹ï¼Œå¹¶åœ¨è®­ç»ƒå‰åŽåº”ç”¨è‚¿ç˜¤å’Œç—…ç¶ç‰¹å®šçš„å¤„ç†æ¥æé«˜åˆ†å‰²æ€§èƒ½ã€‚ä»Ž MRI ä¸­æå–çš„æ”¾å°„ç»„å­¦ç‰¹å¾æœ‰åŠ©äºŽæ£€æµ‹è‚¿ç˜¤äºšåž‹ï¼Œç¡®ä¿æ›´å¹³è¡¡çš„è®­ç»ƒã€‚è‡ªå®šä¹‰ç—…ç¶çº§åˆ«æ€§èƒ½æŒ‡æ ‡ç¡®å®šæ¯ä¸ªæ¨¡åž‹åœ¨é›†æˆä¸­çš„å½±å“ï¼Œå¹¶ä¼˜åŒ–è¿›ä¸€æ­¥ç»†åŒ–é¢„æµ‹çš„åŽå¤„ç†ï¼Œä½¿å·¥ä½œæµç¨‹èƒ½å¤Ÿé’ˆå¯¹æ¯ä¸ªç—…ä¾‹å®šåˆ¶æ¯ä¸ªæ­¥éª¤ã€‚åœ¨ BraTS æµ‹è¯•é›†ä¸Šï¼Œæˆ‘ä»¬çš„æµç¨‹å®žçŽ°äº†ä¸Žå¤šä¸ªæŒ‘æˆ˜ä¸­æŽ’åé å‰çš„ç®—æ³•ç›¸å½“çš„æ€§èƒ½ã€‚è¿™äº›å‘çŽ°è¯å®žï¼Œè‡ªå®šä¹‰ç—…ç¶æ„ŸçŸ¥å¤„ç†å’Œæ¨¡åž‹é€‰æ‹©å¯ä»¥äº§ç”Ÿé²æ£’çš„åˆ†å‰²ï¼Œè€Œæ— éœ€å°†æ–¹æ³•é”å®šåˆ°ç‰¹å®šçš„ç½‘ç»œæž¶æž„ã€‚æˆ‘ä»¬çš„æ–¹æ³•å…·æœ‰åœ¨ä¸´åºŠå®žè·µä¸­è¿›è¡Œå®šé‡è‚¿ç˜¤æµ‹é‡çš„æ½œåŠ›ï¼Œæ”¯æŒè¯Šæ–­å’Œé¢„åŽã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šè®ºæ–‡æ—¨åœ¨è§£å†³è„‘è‚¿ç˜¤åœ¨å¤šå‚æ•° MRI å›¾åƒä¸Šçš„ç²¾ç¡®åˆ†å‰²é—®é¢˜ï¼Œå°¤å…¶æ˜¯åœ¨è‚¿ç˜¤ç±»åž‹å¤šæ ·ã€å½¢æ€å„å¼‚çš„æƒ…å†µä¸‹ã€‚çŽ°æœ‰æ–¹æ³•é€šå¸¸éš¾ä»¥åœ¨ä¸åŒè‚¿ç˜¤ç±»åž‹ä¹‹é—´æ³›åŒ–ï¼Œé²æ£’æ€§è¾ƒå·®ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯æž„å»ºä¸€ä¸ªçµæ´»ã€è‡ªé€‚åº”çš„åˆ†å‰²æµç¨‹ï¼Œè¯¥æµç¨‹èƒ½å¤Ÿæ ¹æ®è‚¿ç˜¤çš„ç‰¹æ€§ï¼ˆé€šè¿‡æ”¾å°„ç»„å­¦ç‰¹å¾æå–ï¼‰é€‰æ‹©åˆé€‚çš„æ¨¡åž‹ï¼Œå¹¶é’ˆå¯¹æ¯ä¸ªç—…ç¶è¿›è¡Œç²¾ç»†åŒ–çš„åŽå¤„ç†ã€‚é€šè¿‡è¿™ç§æ–¹å¼ï¼Œå¯ä»¥æé«˜åˆ†å‰²çš„å‡†ç¡®æ€§å’Œæ³›åŒ–èƒ½åŠ›ã€‚

**æŠ€æœ¯æ¡†æž¶**ï¼šè¯¥æµç¨‹åŒ…å«ä»¥ä¸‹ä¸»è¦æ¨¡å—ï¼š1) æ•°æ®é¢„å¤„ç†ï¼›2) æ”¾å°„ç»„å­¦ç‰¹å¾æå–å’Œè‚¿ç˜¤äºšåž‹è¯†åˆ«ï¼›3) åŸºäºŽè‚¿ç˜¤äºšåž‹çš„æ¨¡åž‹é€‰æ‹©å’Œè®­ç»ƒï¼›4) ç—…ç¶çº§æ¨¡åž‹é›†æˆï¼›5) åŽå¤„ç†å’Œåˆ†å‰²ç»“æžœä¼˜åŒ–ã€‚æ•´ä¸ªæµç¨‹æ˜¯æ¨¡å—åŒ–çš„ï¼Œå¯ä»¥æ ¹æ®å…·ä½“ä»»åŠ¡è¿›è¡Œè°ƒæ•´ã€‚

**å…³é”®åˆ›æ–°**ï¼šè¯¥æ–¹æ³•æœ€é‡è¦çš„åˆ›æ–°ç‚¹åœ¨äºŽå°†æ”¾å°„ç»„å­¦ç‰¹å¾ä¸Žç—…ç¶çº§æ¨¡åž‹é›†æˆç›¸ç»“åˆã€‚æ”¾å°„ç»„å­¦ç‰¹å¾ç”¨äºŽæŒ‡å¯¼æ¨¡åž‹é€‰æ‹©å’Œè®­ç»ƒï¼Œä½¿å¾—æ¨¡åž‹èƒ½å¤Ÿæ›´å¥½åœ°é€‚åº”ä¸åŒç±»åž‹çš„è‚¿ç˜¤ã€‚ç—…ç¶çº§æ¨¡åž‹é›†æˆåˆ™å…è®¸é’ˆå¯¹æ¯ä¸ªç—…ç¶é€‰æ‹©æœ€åˆé€‚çš„æ¨¡åž‹ï¼Œä»Žè€Œæé«˜åˆ†å‰²çš„å‡†ç¡®æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šè®ºæ–‡ä¸­ä½¿ç”¨äº†å¤šç§åˆ†å‰²æ¨¡åž‹ï¼Œå¹¶æ ¹æ®æ”¾å°„ç»„å­¦ç‰¹å¾é€‰æ‹©åˆé€‚çš„æ¨¡åž‹è¿›è¡Œè®­ç»ƒã€‚ç—…ç¶çº§æ¨¡åž‹é›†æˆçš„æƒé‡æ˜¯æ ¹æ®è‡ªå®šä¹‰çš„ç—…ç¶çº§åˆ«æ€§èƒ½æŒ‡æ ‡ç¡®å®šçš„ã€‚åŽå¤„ç†æ­¥éª¤åŒ…æ‹¬å½¢æ€å­¦æ“ä½œå’Œæ¡ä»¶éšæœºåœºï¼ˆCRFï¼‰ä¼˜åŒ–ï¼Œä»¥è¿›ä¸€æ­¥æé«˜åˆ†å‰²ç»“æžœçš„è´¨é‡ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

è¯¥æ–¹æ³•åœ¨ BraTS 2025 Lighthouse Challenge çš„å¤šä¸ªæ•°æ®é›†ä¸Šè¿›è¡Œäº†æµ‹è¯•ï¼ŒåŒ…æ‹¬ PEDã€MENã€MEN-RT å’Œ METã€‚å®žéªŒç»“æžœè¡¨æ˜Žï¼Œè¯¥æ–¹æ³•å–å¾—äº†ä¸Žé¡¶å°–ç®—æ³•ç›¸å½“çš„æ€§èƒ½ï¼Œè¯æ˜Žäº†å…¶åœ¨ä¸åŒç±»åž‹è„‘è‚¿ç˜¤åˆ†å‰²ä»»åŠ¡ä¸Šçš„é²æ£’æ€§å’Œæ³›åŒ–èƒ½åŠ›ã€‚å…·ä½“æ€§èƒ½æ•°æ®æœªåœ¨æ‘˜è¦ä¸­ç»™å‡ºï¼Œä½†å¼ºè°ƒäº†å¯ä¸Žé¡¶å°–ç®—æ³•åª²ç¾Žã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæžœå¯åº”ç”¨äºŽä¸´åºŠè„‘è‚¿ç˜¤è¯Šæ–­å’Œæ²»ç–—è®¡åˆ’åˆ¶å®šã€‚ç²¾ç¡®çš„è‚¿ç˜¤åˆ†å‰²èƒ½å¤Ÿå¸®åŠ©åŒ»ç”Ÿæ›´å‡†ç¡®åœ°è¯„ä¼°è‚¿ç˜¤çš„å¤§å°ã€ä½ç½®å’Œå½¢æ€ï¼Œä»Žè€Œåˆ¶å®šæ›´æœ‰æ•ˆçš„æ²»ç–—æ–¹æ¡ˆã€‚æ­¤å¤–ï¼Œè¯¥æ–¹æ³•è¿˜å¯ä»¥ç”¨äºŽç›‘æµ‹è‚¿ç˜¤çš„æ²»ç–—ååº”ï¼Œè¯„ä¼°æ²»ç–—æ•ˆæžœã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Robust and generalizable segmentation of brain tumors on multi-parametric magnetic resonance imaging (MRI) remains difficult because tumor types differ widely. The BraTS 2025 Lighthouse Challenge benchmarks segmentation methods on diverse high-quality datasets of adult and pediatric tumors: multi-consortium international pediatric brain tumor segmentation (PED), preoperative meningioma tumor segmentation (MEN), meningioma radiotherapy segmentation (MEN-RT), and segmentation of pre- and post-treatment brain metastases (MET). We present a flexible, modular, and adaptable pipeline that improves segmentation performance by selecting and combining state-of-the-art models and applying tumor- and lesion-specific processing before and after training. Radiomic features extracted from MRI help detect tumor subtype, ensuring a more balanced training. Custom lesion-level performance metrics determine the influence of each model in the ensemble and optimize post-processing that further refines the predictions, enabling the workflow to tailor every step to each case. On the BraTS testing sets, our pipeline achieved performance comparable to top-ranked algorithms across multiple challenges. These findings confirm that custom lesion-aware processing and model selection yield robust segmentations yet without locking the method to a specific network architecture. Our method has the potential for quantitative tumor measurement in clinical practice, supporting diagnosis and prognosis.

